___

• 1. Katzung BG. Basic&Clinical Pharmacology, In: Cancer Chemotherapy. 6th edition, Ed. Salmon SE, Sartorelli AC. Lebanon; 1995, p. 831.
• 2. Kayaalp SO. Rasyonel tedavi yönünden Tıbbi Farmakoloji, Cilt I, dokuzuncu baskı, Ankara: Hacettepe Taş; 2000.
• 3. Carles J, Nogue M, Domenech M, Perez C, Saigi E, Villadiego K, et al. Carboplatin-gemcitabine treatment of patients with transitional cell carcinoma of the bladder and impaired renal function. Oncology 2000;59:24-7.
• 4. Chang AY, Hui L, Asbury R, Boros L, Garrow G, Rubins J. Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer. Cancer Chemother Pharmacol 1999;44 Suppl:S26-8.
• 5. Shi TZ, Yan JL. Therapeutic effect of carboplatin and etoposide combinative therapy on 123 lung cancer cases. Zhonghua Zhong Liu Za Zhi 1994;16:384-6.
• 6. Hardman GJ, Limbird Lee E, Molinoff PB, Ruddon RW, Gilman AG. Goodman Gilman’s the pharmacological basis of therapeutics. In: Antineoplastic agents. 9th ed. Ed. Chabner BA, Allegra CJ, Curt GA et al. International edition: The McGraw-Hill Companies; 1996, p.1237.
• 7. Holland HK, Dix SP, Geller RB, Devine SM, Heffner LT, Connaghan DG, et al. Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care. J Clin Oncol 1996;14:1156-64.
• 8. Ghalie R, Williams SF, Valentino LA, Feingold J, Korenblit AD, Adler SS, et al. Tandem peripheral blood progenitor cell transplants as initial therapy for metastatic breast cancer. Biol Blood Marrow Transplant 1995;1:40-6.
• 9. Jones RB, Shpall EJ, Ross M, Coniglio D, Affronti ÖML, Peters WP. High-dose carboplatin, cyclophosphamide, and BCNU with autologous bone marrow support: Excessive hepatic toxicity. Cancer Chemother Pharmacol 1990;26:155-6.
• 10. Demirer T, Ilhan O, Mandel NM, Arat M, Gunel N, Celebi H, et al. A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies. Bone Marrow Transplant 2000;25:697-703.
• 11. Welborn JL, Kopecky KJ, Meyers FJ, Veith R, Shurafa M, Doroshow JH, et al. Carboplatin infusion in relapsed and refractory acute myeloid leukemia: A Southwest Oncology Group trial. Leukemia 1995;9:1126-9.
• 12. Chu G, Mantin R, Shen YM, Baskett G, Sussman H. Massive cisplatin overdose by accidental substitution for carboplatin: Toxicity and management. Cancer 1993;72:3707-14.
• 13. Ettinger LJ, Krailo MD, Gaynon PS, Hammond GD. A phase I study of carboplatin in children with acute leukemia in bone marrow relapse. A report from the Childrens Cancer Group. Cancer 1993;72:917-22.
• 14. Wiedemann GJ, d'Oleire F, Knop E, Eleftheriadis S, Bucsky P, Feddersen S, et al. Ifosfamide and carboplatin combined with 41.8 degrees C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma. Cancer Res 1994;54:5346-50.
• 15. Bacha DM, Caparros-Sison B, Allen JA, Walker R, Tan CT. Phase I study of carboplatin (CBDCA) in children with cancer. Cancer Treat Rep 1986;70:865-9.
• 16. Ettinger LJ, Ivy P, Gaynon PS, Ettinger AG, Liu-Mares W, Krailo MD. A phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow: A report of the Children's Cancer Group. Cancer 1986;80:311-6.
• 17. Welborn JL, Kopecky KJ, Meyers FJ, Veith R, Shurafa M, Doroshow JH, et al. Carboplatin infusion in relapsed and refractory acute myeloid leukemia-a Southwest Oncology Group trial. Leukemia 1995;9:1126-9.
• 18. Baytop T. Therapy with medicinal plants in Turkey. 2nd edition, İstanbul: Nobel Tıp Kitabevleri; 1999.
• 19. Zeybek N. Medical plants of Turkey (I. The North-Eastern “Pontus” of Anatolia). First Edition, İzmir: Ege Üniversitesi Matbaası, Ege Üniversitesi Tıp Fakültesi Neşriyatı; No: 8, 1960.
• 20. Kurucu S, Işık Ç. Akdeniz bölgesi susam tohumlarında (Sesamun indicum L.) yağ asitleri ve sesamolin analizi. İçinde: Maksut Coşkun, editör. XI. Bitkisel İlaç Hammaddeleri Toplantısı, Proceedings of The XIth Symposium on Plant Originated Crude Drugs. 1996 May 22-24; Ankara, Ankara Üniversitesi Eczacılık Fakültesi Yayınları; 1996. p. 226-231.
• 21. Akgül A. Baharat Bilimi & Teknolojisi. Birinci Baskı, Ankara; Gıda Teknolojisi Derneği Yayınları: No: 15, 1993.
• 22. Takeuchi H, Mooi LY, Inagaki Y, He P. Hypoglycemic effect of a hot-water extract from defatted sesame (Sesamum indicum L.) seed on the blood glucose level in genetically diabetic KK-Ay mice. Biosci Biotechnol Biochem 2001;65:2318-21.
• 23. Anila L, Vijayalakshmi NR. Beneficial effects of flavonoids from Sesamum indicum, Emblica officinalis and Momordica charantia. Phytother Res 2000;14:592-5.
• 24. Yun TK. Update from Asia. Asian studies on cancer chemoprevention. Ann N Y Acad Sci 1999;889:157-92.
• 25. Özkal N, Atasü (Sayron) E. Doğal bileşiklerin etkilerine örnekler. İçinde: K. Hüsnü Can Başer, editör. IX.Bitkisel İlaç Hammaddeleri Toplantısı. Proceedings of the 9th Symposium on Plant Drugs; 1991 May 16-19; Eskişehir, Anadolu Üniversitesi Yayınları; 1992. p. 188-197.
• 26. El Garhy MF, Mahmoud LH. Anthelminthic efficacy of traditional herbs on Ascaris lumbricoides. J Egypt Soc Parasitol 2002;32:893-900.
• 27. Jakovljevic V, Raskovic A, Popovic M, Sabo J. The effect of celery and parsley juices on pharmacodynamic activity of drugs involving cytochrome P450 in their metabolism. Eur J Drug Metab Pharmacokinet 2002;27:153-6.
• 28. Momin RA, Nair MG. Antioxidant, cyclooxygenase and topoisomerase inhibitory compounds from Apium graveolens Linn. seeds. Phytomedicine 2002;9:312-8.
• 29. Ahmed B, Alam T, Varshney M, Khan SA. Hepatoprotective activity of two plants belonging to the Apiaceae and the Euphorbiaceae family. J Ethnopharmacol 2002;79:313-6.
• 30. Singh A, Handa SS. Hepatoprotective activity of Apium graveolens and Hygrophila auriculata against paracetamol and thioacetamide intoxication in rats. J Ethnopharmacol 1995;49:119-26.
• 31. Ching LS, Mohamed S. Alpha-tocopherol content in 62 edible tropical plants. J Agric Food Chem 2001;49:3101-5.
• 32. Momin RA, Nair MG. Mosquitocidal, nematicidal, and antifungal compounds from Apium graveolens L. seeds. J Agric Food Chem 2001;49:142-5.
• 33. Atta AH, Alkofahi A. Anti-nociceptive and anti-inflammatory effects of some Jordanian medicinal plant extracts. J Ethnopharmacol 1998;60:117-24.
• 34. Zheng GQ, Kenney PM, Zhang J, Lam LK. Chemoprevention of benzo[a]pyrene-induced forestomach cancer in mice by natural phthalides from celery seed oil. Nutr Cancer 1993;19:77-86.
• 35. Ko FN, Huang TF, Teng CM. Vasodilatory action mechanisms of apigenin isolated from Apium graveolens in rat thoracic aorta. Biochim Biophys Acta 1991;1115:69-74.
• 36. Öztürk Y, Başer KHC, Aydın S. Hepatoprotective (antihepatotoxic) plants in Turkey. İçinde: K. Hüsnü Can Başer, editör. IX.Bitkisel İlaç Hammaddeleri Toplantısı. Proceedings of the 9th Symposium on Plant Drugs; 1991 May 16-19; Eskişehir, Anadolu Üniversitesi Yayınları; 1992. p. 40-50.
• 37. Özbek H, Öztürk M, Öztürk A, Ceylan E, Yener Z. Determination of lethal doses of volatile and fixed oils of several plants. East J Med 2004;9:4-6.
• 38. Teicher BA, Holden SA, Herman TS, Epelbaum S Pardee AB, Dezube B. Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo. Anticancer Res 1991;11:1555-60.
• 39. Meier-Bratschi A, Lutz WK, Schlatter C. Methylation of liver DNA of rat and mouse by N-nitrosodimethylamine formed in vivo from dimethylamine and nitrite. Food Chem Toxicol 1983;21:285-9.
• 40. Sümbüloğlu K, Sümbüloğlu V: Biyoistatistik, 8. baskı, Ankara; Hatiboğlu Yayınevi: 1998.
• 41. Murray RK, Granner DK, Mayes PA Rodwell VW. Harper’s Biochemistry. In: Enzymes. General Properties. 25th edition. Rodwell VW, Kennelly PJ. USA: 2000: p:83.